Best health care companies in Bryan, TX

Surgery Partners acquires, develops and manages free-standing ambulatory surgical centers (ASCs) in partnership with leading physicians. The company owns and operates twelve ASCs. As one of the largest ASC operators in the Southeast, Surgery Partners is dedicated to clinical excellence in outpatient surgery services and provides its centers with experienced and efficient operations leadership, development expertise, and practice partnership.

Operates As A General Medical Or Surgical Hospital (100%).

BPL Plasma collects blood plasma to help create high-quality, life-saving therapies for patients worldwide and improve our donors' lives, too. Learn more.

Baylor Scott & White Health has a strong commitment to innovation, collaboration, integrity and compassion for patients. How can we help you?

Learn about top ambulatory surgery center (ASC) management company AMSURG, chosen by physicians at 250+ single & multispecialty ASCs across the nation.

Gulf Coast Regional Blood Center is an independent, nonprofit blood center that gathers blood through donations and provides blood, blood components and related services.

Clinical Pathology Laboratories, Inc. (CPL) has served the medical community for over sixty years. Over 1850 employees work at our 100,000 square foot main laboratory facility and at our remote laboratory operations located across the Southwest. CPL has adopted a pathology-involved philosophical approach for each market served. That is, CPL has affiliated with over 150 pathologists throughout the Southwest. The CPL-affiliate pathologist strategy allows CPL to provide a seamless operation, offering clients "Local" cytology/histology services combined with pathology directed clinical testing. CPL believes that it is better positioned to offer clients the cost efficiencies available through a large independent laboratory while sustaining the continuum of care of local pathology. CPL selected the current pathology affiliates based on proven leadership within their respective medical communities.

Airrosti is an outcome-based healthcare group filling the value gap in musculoskeletal care. Airrosti providers are committed to a patient-centered set of clinical pathways designed to reduce variability in care and improve recovery times while preventing unnecessary imaging, surgeries, and other costly care. Patient reported outcomes and episodic claim studies reveal that Airrosti shortens recovery times and creates lasting results at a fraction of current medical costs. This effectiveness and efficiency has created collaborative partnerships with employers, carriers, physicians, and health systems. This collaborative approach is leading to high value member and payor prevention products, as well as innovative accountable care solutions.

Community Hospitals and Wellness Centers provides healthcare services in the United States. It offers medical services, such as cardiac catheterization and rehabilitation, cardiopulmonary care, respiratory care, cancer care, ER/trauma, dialysis, ICU/TCU, pharmacy, hospitalist, imaging/radiology, lab, medical record, neurology, child birth education program, online nursery, nutrition therapy, OB/maternity, occupational and physical therapy, pain management, radiation oncology, rehabilitation, speech therapy, surgical, and wound care, as well as ear, nose, and throat care services. It also provides patient services, such as community health assessments, counseling, financial assistance, and insurance information. In addition, the company provides health education services, such as community programs, classes, and certifications; continence clinic and Dilworth center; food guidelines; medical staff information; and patient navigation, including breast health, pregnancy care, cancer, and congestive heart failure. Community Hospitals and Wellness Centers was founded in 1969 and is based in Bryan, Ohio with locations in Montpelier and Archbold, Ohio.

Since 1962, MRC has provided senior living in Texas that aims to be best - that is, best communities, services, staff and residents. Learn more:

iBio develops and offers product applications of its iBioLaunch™ and iBioModulator™ platforms, providing collaborators full support for turn-key implementation of its technology for both proprietary and biosimilar products. The iBioLaunch platform is a proprietary, transformative technology for development and production of biologics using transient gene expression in unmodified green plants. Advantages over other systems include: success with proteins difficult or impossible to produce with other methods; broadly applicable to biologics, including monoclonal antibodies, other therapeutic proteins and vaccines; enables rapid development and validation of modular, scalable, and optionally robotic, multi-product manufacturing facilities; production time measured in weeks instead of months or more. Additional benefits include a practically unlimited surge capacity for remedial action against bioterrorism and pandemic disease; product entry that is unconstrained by traditional process patents, and significantly lower capital and operating costs for comparable production.